425: Berto SPAC Eyes OnMed Healthcare Merger

Berto Acquisition Corp. and OnMed LLC have signed a non-binding letter of intent for a potential business combination, aiming to address healthcare access challenges.

Summary

• Berto Acquisition Corp. (NASDAQ: TACO, TACOW), a special purpose acquisition company, and OnMed LLC, a developer of healthcare infrastructure solutions, have entered into a non-binding Letter of Intent for a potential business combination.
• OnMed's core offering is the OnMed CareStation™, an 8x10 foot 'Clinic-in-a-Box' designed to provide personalized, patient-first healthcare.
• The CareStations aim to address America's healthcare access crisis, where 80% of US counties are considered healthcare deserts and over 120 million Americans lack adequate access.
• Each CareStation provides one-on-one clinical consultation with real-time diagnostic tools, vital sign monitoring, and e-prescriptions, managed by a live clinician via a 65-inch screen.
• OnMed reports that 85% of patients are fully diagnosed without a specialist referral, and 50% of patients stated they would have otherwise gone to the ER or urgent care.
• Patient satisfaction is high, with a 4.96 out of 5 score and 99% willingness to return or recommend.
• CareStations can be deployed for a fraction of the cost of traditional in-office clinics, which can exceed $2.5 million to build and run, and do not require in-office staff.
• A CareStation can be fully operational in just 30 days from contract to deployment.
• OnMed currently has CareStations contracted across seven states and Puerto Rico, with significant expansion planned for 2026.
• Karthik Ganesh, the current CEO of OnMed, is expected to lead the combined publicly listed company.

Sentiment

Score: 7

Explanation: The announcement of a non-binding LOI for a business combination is generally positive for a private company seeking public listing and capital for growth. OnMed's business model addresses a critical market need with strong reported patient satisfaction and operational efficiency. However, the non-binding nature and numerous closing conditions introduce significant uncertainty, preventing a higher score.

Positives

• OnMed addresses a critical and massive market need: America's healthcare access crisis, with 80% of US counties qualifying as healthcare deserts and 120M+ Americans lacking adequate access.
• The OnMed CareStation™ offers a scalable and cost-effective healthcare infrastructure solution, significantly cheaper to deploy and operate than traditional clinics (which can cost upwards of $2.5M).
• High patient satisfaction is evidenced by a 4.96 out of 5 score and 99% willingness to return or recommend, indicating strong product-market fit and positive user experience.
• CareStations demonstrate clinical effectiveness, with 85% of patients fully diagnosed without a specialist referral and 50% of patients avoiding ER or urgent care visits.
• Rapid deployment capability allows a CareStation to be fully operational in just 30 days from contract, enabling quick expansion into underserved areas.
• OnMed possesses an 'emerging free cash flow positive model' and an 'IP-protected platform,' which are attractive financial and strategic characteristics.
• OnMed has received multiple industry recognitions, including TIME's 2025 List of the Best Inventions, the 2025 CES Picks Award, and inclusion in Inc. 5000's list of America's Fastest Growing Private Companies.
• Karthik Ganesh, OnMed's CEO, will lead the combined company, providing experienced leadership and continuity for the innovative business model.

Negatives

• The agreement is a non-binding Letter of Intent, meaning there is no guarantee that a definitive agreement will be successfully negotiated or that the proposed transaction will be consummated.
• The transaction is subject to numerous conditions, including completion of due diligence, negotiation of a definitive agreement, board and equity holder approval, and regulatory approvals, each of which could prevent closing.
• No specific financial terms, valuation, or capital structure details of the proposed business combination were disclosed in the filing.
• The filing contains extensive forward-looking statements and disclaimers, highlighting significant risks and uncertainties inherent in such a transaction.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the termination of the negotiations and any subsequent definitive agreements with respect to the proposed business combination.
• The possibility that the terms and conditions set forth in any definitive agreements with respect to the proposed business combination may differ materially from the terms and conditions set forth in the letter of intent.
• The outcome of any legal proceedings that may be instituted against the parties following the announcement of the proposed business combination and any definitive agreements with respect thereto.
• The inability to complete the proposed transaction, including due to failure to obtain approval of the shareholders of OnMed and Berto or other conditions to closing.
• The inability to obtain or maintain the listing of the post-acquisition company's common stock on Nasdaq, the New York Stock Exchange, or another national securities exchange following the proposed transaction.
• The risk that the proposed transaction disrupts current plans and operations as a result of the announcement and consummation of the proposed transaction.
• The ability to recognize the anticipated benefits of the proposed transaction, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, and its ability to retain its key employees.
• Costs related to the proposed transaction.
• Changes in applicable laws or regulations.
• Other risks and uncertainties included in documents filed or to be filed with the SEC by OnMed and Berto.

Future Outlook

OnMed plans to significantly expand its CareStation footprint in 2026. The combined company expects to leverage OnMed's strong growth, emerging free cash flow positive model, IP-protected platform, and massive addressable market, potentially extending further with AI technologies. The proposed business combination aims to create a publicly listed entity led by OnMed's current CEO, Karthik Ganesh.

Management Comments

• "We are excited to partner with the Berto team because of their significant experience and success in scaling tech-enabled infrastructure solutions." Karthik Ganesh, CEO of OnMed.
• "OnMed's purpose is to improve the quality of life and sense of wellbeing in the communities where CareStations are deployed." Karthik Ganesh, CEO of OnMed.
• "With CareStations having fully diagnosed 85% of patients without a specialist referral and supported the 50% of patients who said they would otherwise had gone to the ER or urgent care, we are proving that this model works." Karthik Ganesh, CEO of OnMed.
• "We could not be more pleased and excited to work with Karthik and his team at OnMed, who have created a scalable solution that combines the best of technology and innovative infrastructure solutions." Harry You, Chairman of Berto Acquisition Corp.
• "OnMed has the financial and business characteristics we like to see for the companies we have taken public – strong growth, an emerging free cash flow positive model, an IP-protected platform, and a massive addressable market with the potential to be extended further by cutting edge technologies like AI." Harry You, Chairman of Berto Acquisition Corp.

Industry Context

This proposed business combination aligns with the growing trend of digital health and decentralized healthcare solutions, particularly in addressing healthcare access disparities. OnMed's CareStation model directly tackles the 'healthcare desert' issue prevalent in the U.S., offering a scalable alternative to traditional clinics and complementing existing telemedicine services by providing in-person diagnostic capabilities. The SPAC merger structure is a common pathway for innovative private companies like OnMed to access public markets and capital for expansion.

Comparison to Industry Standards

• OnMed's CareStation model offers a significant cost advantage compared to traditional in-office clinics, which can cost upwards of $2.5 million to build and run, by eliminating the need for in-office staff and reducing infrastructure costs.
• The rapid deployment time of 30 days from contract to operational status for a CareStation is significantly faster than the typical timeline for establishing a new physical clinic.
• OnMed's reported 85% diagnosis rate without specialist referral and 50% reduction in ER/urgent care visits demonstrate a higher level of comprehensive care delivery compared to basic telehealth platforms that often require follow-up in-person visits for diagnostics.
• The 4.96 out of 5 patient satisfaction score and 99% willingness to return/recommend are exceptionally high, indicating strong patient acceptance and effectiveness, potentially surpassing average satisfaction rates for both traditional clinics and pure telehealth services.

Management Changes

Stakeholder Impact

• Shareholders (Berto): Potential for value creation through the acquisition of an innovative, high-growth healthcare company, but also exposure to risks associated with the transaction's completion and future performance.
• Employees (OnMed): Karthik Ganesh, current CEO, will lead the combined company, suggesting continuity in leadership. OnMed's recognition as a '2025 Great Place to Work' indicates a positive existing employee environment.
• Customers/Patients (OnMed): Expected continued and expanded access to OnMed CareStations, potentially improving healthcare access and outcomes in underserved communities.
• Partners (OnMed): Continued and expanded partnerships with payors, providers, government agencies, employers, and educational institutions are anticipated with increased capital and public profile.

Next Steps

• Completion of due diligence by both Berto Acquisition Corp. and OnMed LLC.
• Negotiation and execution of a definitive business combination agreement.
• Satisfaction of all conditions negotiated within the definitive agreement.
• Obtaining board and equity holder approval from both Berto and OnMed.
• Securing necessary regulatory approvals.
• Berto or a newly formed holding company will prepare and file a registration statement, including a proxy statement/prospectus, with the SEC.
• Mailing of the proxy statement/prospectus to Berto's shareholders.
• Potential significant expansion of OnMed's CareStation footprint in 2026.

Key Dates

Recommendation

The announcement of a non-binding Letter of Intent for a business combination with OnMed LLC presents a potentially attractive opportunity for Berto Acquisition Corp. OnMed's innovative CareStation model addresses a significant market need, demonstrates strong patient satisfaction, and has a clear growth trajectory. However, the non-binding nature of the LOI and the numerous conditions precedent to closing introduce substantial execution risk. Investors should hold existing positions and await further details, including definitive agreement terms, valuation, and a comprehensive proxy statement/prospectus, before making further investment decisions. The lack of financial specifics at this stage makes a stronger recommendation premature.

Keywords

SPAC, Healthcare Infrastructure, OnMed CareStation, Telehealth, Healthcare Access, Special Purpose Acquisition Company, Business Combination, Medical Technology, Digital Health, TACO, OnMed LLC